Type 2 diabetes is one of the fastest growing chronic diseases world-wide primarily due to increasing sedentary lifestyle and prevalence of obesity. Whether lifestyle intervention to prevent type 2 diabetes is working in practice has thus far remained unclear. The main aim of the Finnish Diabetes Prevention Study (DPS) was to assess whether the onset of type 2 diabetes can be prevented by life-style intervention in high-risk subjects. METHODS: DPS is a prospective controlled trial carried out in 5 clinics in Finland. 522 middle-aged (mean age 55 years), overweight (mean BMI 31 kgam 2 ) were randomised into either the intervention (IG) or control group (CG). The subjects in the IG received individual advice to reduce weight, dietary intake of energy and total and saturated fats and to increase ®bre intake and physical activity. During the 1st year the intervention in the IG was intense including frequent consultation visits, and thereafter the main aim was to maintain the lifestyle changes reached. The CG also received general advice about healthy life-style at randomisation and every annual follow-up visit. The primary outcome in the DPS was incident diabetes. RESULTS: After 1, 2 and 3 years weight reductions were 4.2, 3.5 and 3.2 kg in the IG and 0.8, 0.8 and 0.7 kg in the CG. At 3 years the cumulative incidence of diabetes was 8% (95% CI 5 ± 12%) in the IG and 20% (15 ± 25%) in the CG. The cumulative incidence of diabetes was reduced by 58% (p 0.0003) in the IG compared with the CG during the entire trial. When groups were combined and divided in weight change quintiles (weight change from baseline to ®rst annual visit) the mean weight change and odds ratio for developing diabetes during the trial were as follows. Q1: 11% weight reduction ? OR 0.17; Q2: 5% weight reduction ? OR 0.39; Q3: 2% weight reduction ? OR 0.87; Q4: 0% weight change ? OR 1 (reference); Q5: 3% weight increase ? OR 2.18. CONCLUSIONS: Controlled, randomised DPS trial including high-risk subjects demonstrated that type 2 diabetes can be effectively prevented by lifestyle intervention. Weight change during the ®rst year of intervention was a good predictor of diabetes risk during the entire follow-up.
INTRODUCTION:
Type 2 diabetes is one of the fastest growing chronic diseases world-wide primarily due to increasing sedentary lifestyle and prevalence of obesity. Whether lifestyle intervention to prevent type 2 diabetes is working in practice has thus far remained unclear. The main aim of the Finnish Diabetes Prevention Study (DPS) was to assess whether the onset of type 2 diabetes can be prevented by life-style intervention in high-risk subjects. METHODS: DPS is a prospective controlled trial carried out in 5 clinics in Finland. 522 middle-aged (mean age 55 years), overweight (mean BMI 31 kgam 2 ) were randomised into either the intervention (IG) or control group (CG). The subjects in the IG received individual advice to reduce weight, dietary intake of energy and total and saturated fats and to increase ®bre intake and physical activity. During the 1st year the intervention in the IG was intense including frequent consultation visits, and thereafter the main aim was to maintain the lifestyle changes reached. The CG also received general advice about healthy life-style at randomisation and every annual follow-up visit. The primary outcome in the DPS was incident diabetes. RESULTS: After 1, 2 and 3 years weight reductions were 4.2, 3.5 and 3.2 kg in the IG and 0.8, 0.8 and 0.7 kg in the CG. At 3 years the cumulative incidence of diabetes was 8% (95% CI 5 ± 12%) in the IG and 20% (15 ± 25%) in the CG. The cumulative incidence of diabetes was reduced by 58% (p 0.0003) in the IG compared with the CG during the entire trial. When groups were combined and divided in weight change quintiles (weight change from baseline to ®rst annual visit) the mean weight change and odds ratio for developing diabetes during the trial were as follows. Q1: 11% weight reduction ? OR 0.17; Q2: 5% weight reduction ? OR 0.39; Q3: 2% weight reduction ? OR 0.87; Q4: 0% weight change ? OR 1 (reference); Q5: 3% weight increase ? OR 2.18. CONCLUSIONS: Controlled, randomised DPS trial including high-risk subjects demonstrated that type 2 diabetes can be effectively prevented by lifestyle intervention. Weight change during the ®rst year of intervention was a good predictor of diabetes risk during the entire follow-up.
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A quantitative trait locus for insulin sensitivity adjusted for adiposity is linked to chromosome 3 
AG

INTRODUCTION:
Numerous studies have documented the existence of a cluster of metabolic parameters, which includes insulin sensitivity, dyslipidemia, and high blood pressure, which are adversely affected by increasing levels of adiposity. The search for genes involved in the expression of obesity, and diabetes have been among the focal points of the San Antonio Family Heart Study, a large, family based study to examine the genetics of risk for atherosclerosis in Mexican Americans. Here we report the results of a genome-wide scan for insulinaglucose ratio adjusted for BMI. METHODS: This analysis used 361 individuals distributed over 10 extended families. All individuals were genotyped for over 400 markers yielding an average map density of 10 centiMorgans (cM). Linkage analysis was conducted using a variance component approach implemented in the program package SOLAR. RESULTS: The additive genetic heritability for the insulinaglucose ratio was 0.56 AE 0.10 (p-value`0.0000001). In a multipoint linkage analysis the maximum LOD score detected was 3.9 at 131 cM on chromosome 3 (near D3S2460). CONCLUSIONS: Recently several other studies (Kissebah et al. 2000; Mitchell et al. 2000; Vionnet et al. 2000; Weyer et al. 2000) have reported evidence of linkage on the q-arm of chromosome 3 for various traits related to obesity, insulin sensitivity, and diabetes. However, the signal reported here is the largest to date for this region of chromosome 3. While the location of the maximal linkage signals varies somewhat among these various studies, there is overlap of the multipoint LOD curves. In addition, several promising positional candidate genes for obesity-and diabetes-related traits have been mapped to this region. As a result we feel that there is strong evidence for a gene in this region of chromosome 3 with a signi®cant effect on insulin sensitivity and obesity.
REFERENCES:
Kissebah et al. (2000) This study intended to investigate, ®rstly, whether triglyceride content (intramyocellular, IMTG and extramyocellular, EMTG) is increased in skeletal muscle (gastronemicus) of obese subjects and, secondly, whether an impaired regulation of muscle lipolysis may play a role in this increased triglyceride storage.
In 7 lean (body fat: 22.1 AE 1.6%, age: 58.3 AE 1.4 y) and 7 obese men (BF: 32.7 AE 1.6%, age: 55.1 AE 1.9 y) IMTG and EMTG were determined by means of 1 H-magnetic resonance spectroscopy. In a 2nd experiment, a microdialysis probe was inserted in the gastronemicus muscle to monitor extracellular glycerol concentrations. After an initial calibration period to determine real extracellular glycerol concentrations (zerō ow method), the probe was perfused with increasing concentrations of the b 2 -agonist salbutamol (doses: 1, 10 mM, 45 min periods). Local blood¯ow was determined by means of the ethanol dilution technique.
Both IMTG (0.91 AE 0.10 vs 0.54 AE 0.10% of water resonance, P`0.05) and EMTG (4.50 AE 0.56 vs 1.55 AE 0.26%, P`0.01) were increased in obese subjects as compared to the lean. Interstitial glycerol concentrations were higher in obese as compared to lean subjects (181 AE 14 vs 116 AE 21 mM, P`0.05). Interestingly, the b 2 -adrenergically mediated increase in glycerol concentrations (%change) was signi®cantly blunted in obese as compared to lean subjects (at 1 mM: 10 AE 8 vs 22AE 6%, at 10 mM: 9 AE 8 vs 37AE 7%, P`0.05). Also, the decrease in ethanol outain ratio tended to be less pronounced in the obese (P 0.09), indicating a diminished increase in local muscle blood¯ow. In conclusion, the capacity to increase skeletal muscle lipolysis during b-adrenergic stimulation is impaired in obese subjects. This impairment may play a role in the development of increased skeletal muscle triglyceride stores and consequently insulin resistance.
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Blunted leptin response to glucocorticoids with simultaneous deterioration of insulin resistance in obese individuals There is evidence to suggest that there are signi®cant interactions between leptin and the hypothalamic-pituitary-adrenal axis, one of the principal effector limbs of the stress system. Thus, glucocorticoids stimulate leptin production which in turn directly or indirectly inhibits the production of glucocorticoids, eventually reducing its own production. We wished to examine whether these interactions might differ between obese and lean individuals.
We measured fasting plasma leptin (RIA, Linco Research, mc), insulin and glucose in 15 lean (BMI`25) and 14 obese women (BMI b 30) at 8 AM at two consecutive days, before and after the overnight administration (at 11 pm) of 4 mg of dexamethasone per os. The same study was repeated after at least one week with the simultaneous administration of 40 mg of propranolol at 8 am, 4 PM and 12 midnight during the ®rst day, in order to examine whether the dexamethasone effect is modi®ed by b-adrenergic blockade.
Obese women had approximately 3-fold higher basal leptin levels compared to lean women (48.2 AE 3.7 vs 12.5 AE 1.6 ngaml, respectively), that failed to increase signi®cantly after dexamethasone administration (52.1 AE 4.2 ngaml), in contrast to the signi®cant (p`0.001) and consistent increase observed in the lean group (19.5 AE 2.9 ngaml (p`0.001). In addition, dexamethasone caused signi®cant elevations in insulin levels in both obese and lean (from 18.4 AE 2.4 to 38.0 AE 7.9 IUaL, p`0.02, and from 9.9 AE 2.4 to 13.7 AE 1.4 IUaL, p`0.03, respectively), which were much more pronounced in the obese, re¯ecting a worsening of their insulin resistance.
Fasting glucose levels also increased signi®cantly after dexamethasone in both groups (from 99 AE 4 to 140 AE 8 mgadl, p`0.001 and from 89 AE 3 to 115 AE 5 mgadl, p`0.001, respectively). These elevations were more exaggerated in the obese group, reaching in the majority of cases levels b 126 mgadl. Pretreatment with propranolol did not alter any of the above observed responses.
In conclusion, obese individuals showed a blunted leptin response 9 hours after overnight dexamethasone administration, with simultaneous evidence of signi®cant deterioration of insulin sensitivity and glucose metabolism. It appears that the leptin response to stress is deranged and probably maladaptive in obesity, potentially contributing to the associated metabolic abnormalities.
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Is abdominal subcutaneous adipose tissue divided into metabolic functionally different layers? In a recent paper it has been suggested that the abdominal adipose tissue may be divided into two functionally different layers physically separated by the fascia of Scarpa (1). The layer below the fascia is suggested to be metabolically similar to the visceral fat depots. Likewise, it has been show that the mass of the preperitoneal adipose depot varies in parallel with the mass of the visceral depots (2). The aim of the present study was to examine the lipolytic activity in the super®cial and deep layers of the abdominal, subcutaneous adipose tissue, and in the preperitoneal adipose tissue in vivo during i.v. adrenaline infusion. METHODS: Eight healthy males were examined during rest in the postabsorptive state and during infusion of adrenaline. The measurements were performed with microdialysis. The probes were inserted percutaneously by guidance of ultrasonography. , waist circumference 102 AE 2 cm, FFM 49 AE 3 kg) were studied. All subjects had normal basal serum TG concentrations and normal oral glucose tolerance. After subjects fasted overnight (12-h), VLDL-TG production was determined by bolus injection of [ 2 H 5 ] glycerol (75 mmolakg), and blood sampling at 5, 15, 30, 60, 90, 120 min, and then hourly for 12 h to determine substrate concentrations and glycerol enrichment in plasma and in VLDL-TG. VLDL-TG kinetics were determined by using compartmental modling analysis. RESULTS: Mean basal plasma triglyceride concentration was higher in obese (154 AE 11 mgadL; 1743 AE 120 mmolaL) than in lean (72 AE 15 mgadL; 817 AE 219 mmoaL) subjects (p`0.05). VLDL-TG fractional turnover rate was $ 50% lower in obese (0.54 AE 0.06 poolsah) than in lean (1.15 AE 0.24 poolsah) subjects (p`0.05). However, the absolute rates of VLDL-TG production were similar in lean (0.60 AE 0.12 mmol Á kg FFM 71 Á d
71
) and obese (0.69 AE 0.08 mmol Á kg FFM 71 Á d 71 ) subjects. CONCLUSION: Although basal VLDL-TG fractional turnover is lower in abdominally obese than in lean women, absolute VLDL-TG proudction rate, expressed in relationship to FFM, is the same in lean and obese women because of an increased VLDL-TG pool in obese women.
Data are expressed as mean AE SEM. Supported by a grant from Roche Laboratories.
